Latest filingSep 02, 2026Most recent Form 4
OBIO
Orchestra BioMed Holdings, Inc.
NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$1.06M1 buys
Total selling$7.41M1 sells
Net open-market-$6.34M3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period5transactions
- F · Tax withholding · dominant3 · 60%
- P · Open-market buys1 · 20%
- S · Open-market sells1 · 20%
Activity by reported role
A joint filing can contribute to multiple roles5transactions
- SR · dominant3 · 60%
- Chief financial officer1 · 20%
- PAO1 · 20%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (3)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeSherman DarrenCommon Stock, par value $0.0001 per share ("Common Stock") · Direct
1,134,402Sep 01, 2026
Aiello JoshuaCommon Stock, par value $0.0001 per share · Direct
18,441Aug 26, 2026
Sherman DarrenCommon Stock · Indirect · By son
2,000Aug 26, 2026
Taylor Andrew LawrenceCommon Stock, par value $0.0001 per share · Direct
589,989Aug 26, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- SD-$74.1k
Recent filing activity
Most recent 1 transactions · color = transaction code- SSell09/02-$7.41MSEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
OBIO transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| OBIO | Sherman Darren | SR | sale10b5-1 | 15.0k | -$7.41M | S | — | 0.0% | 09/02 | 09/01 |
Orchestra BioMed Holdings, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Orchestra BioMed Holdings, Inc.?
Sherman Darren, Taylor Andrew Lawrence, Aiello Joshua.
When was the latest reported open-market purchase?
Sherman Darren reported a buy on Aug 26, 2026 valued at $1.06M. Read the SEC filing.
When was the latest reported open-market sale?
Sherman Darren reported a sale on Sep 01, 2026 valued at $7.41M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $63,440.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.